| Year |
Citation |
Score |
| 2024 |
Rowe C, Williams AR, Bisaga A. Changes in Recovery Capital Among Patients Receiving Buprenorphine Treatment for Opioid Use Disorder in a Telehealth Setting. Substance Use & Addiction Journal. 29767342241283174. PMID 39347714 DOI: 10.1177/29767342241283174 |
0.328 |
|
| 2024 |
Shulman M, Greiner MG, Tafessu HM, Opara O, Ohrtman K, Potter K, Hefner K, Jelstrom E, Rosenthal RN, Wenzel K, Fishman M, Rotrosen J, Ghitza UE, Nunes EV, Bisaga A. Rapid Initiation of Injection Naltrexone for Opioid Use Disorder: A Stepped-Wedge Cluster Randomized Clinical Trial. Jama Network Open. 7: e249744. PMID 38717773 DOI: 10.1001/jamanetworkopen.2024.9744 |
0.378 |
|
| 2023 |
Tardelli V, Xu KY, Bisaga A, Levin FR, Fidalgo TM, Grucza RA. Prescription amphetamines in people with opioid use disorder and co-occurring psychostimulant use disorder initiating buprenorphine: an analysis of treatment retention and overdose risk. Bmj Mental Health. 26. PMID 37500184 DOI: 10.1136/bmjment-2023-300728 |
0.309 |
|
| 2023 |
Greiner MG, Shulman M, Opara O, Potter K, Voronca DC, Tafessu HM, Hefner K, Hamilton A, Scheele C, Ho R, Dresser L, Jelstrom E, Fishman M, Ghitza UE, Rotrosen J, ... ... Bisaga A, et al. Surmounting withdrawal to initiate fast treatment with naltrexone (SWIFT): A stepped wedge hybrid type 1 effectiveness-implementation study. Contemporary Clinical Trials. 128: 107148. PMID 36931426 DOI: 10.1016/j.cct.2023.107148 |
0.352 |
|
| 2022 |
Williams AR, Aronowitz S, Gallagher R, Behar E, Gray Z, Bisaga A. A Virtual-First Telehealth Treatment Model for Opioid Use Disorder. Journal of General Internal Medicine. PMID 36456841 DOI: 10.1007/s11606-022-07955-x |
0.321 |
|
| 2022 |
Shulman M, Hu MC, Sullivan MA, Akerman SC, Fratantonio J, Barbieri V, Nunes EV, Bisaga A. Patient characteristics associated with initiation of XR-naltrexone for opioid use disorder in clinical trials. Drug and Alcohol Dependence. 233: 109343. PMID 35131528 DOI: 10.1016/j.drugalcdep.2022.109343 |
0.384 |
|
| 2021 |
Levine A, Clemenza K, Weiss S, Bisaga A, Eitan E, Gerra MC, Donnini C, Gerra G, Garcia B. Discovering Non-Invasive Biomarkers Predictive of Opioid Use Disorder Treatment Response. Cns Spectrums. 26: 173. PMID 34127132 DOI: 10.1017/S1092852920002825 |
0.323 |
|
| 2021 |
Levin FR, Mariani JJ, Pavlicova M, Choi CJ, Basaraba C, Mahony AL, Brooks DJ, Naqvi N, Bisaga A. Lorcaserin treatment for extended-release naltrexone induction and retention for opioid use disorder individuals: A pilot, placebo-controlled randomized trial. Drug and Alcohol Dependence. 219: 108482. PMID 33418204 DOI: 10.1016/j.drugalcdep.2020.108482 |
0.353 |
|
| 2020 |
Kidd JD, Smith JL, Hu MC, Turrigiano EM, Bisaga A, Nunes EV, Levin FR. Medical Student Attitudes Toward Substance Use Disorders Before and After a Skills-Based Screening, Brief Intervention, and Referral to Treatment (SBIRT) Curriculum. Advances in Medical Education and Practice. 11: 455-461. PMID 32636697 DOI: 10.2147/Amep.S251391 |
0.323 |
|
| 2020 |
Tardelli VS, Bisaga A, Arcadepani FB, Gerra G, Levin FR, Fidalgo TM. Prescription psychostimulants for the treatment of stimulant use disorder: a systematic review and meta-analysis. Psychopharmacology. PMID 32601988 DOI: 10.1007/S00213-020-05563-3 |
0.413 |
|
| 2020 |
Nunes EV, Bisaga A, Krupitsky E, Nangia N, Silverman BL, Akerman SC, Sullivan MA. Reply to Kunoe (2020) and Ghosh and Singh (2020) regarding: Nunes et al., Opioid use and dropout from extended-release naltrexone in a controlled trial: implications for mechanism. Addiction. 2020 Feb;115(2):239-246. Addiction (Abingdon, England). PMID 32533597 DOI: 10.1111/Add.15153 |
0.367 |
|
| 2020 |
Ghosh A, Roub F, Bisaga A. Drug treatment of SARS-Cov2: Potential effects in patients with substance use disorders (SUD). Journal of Psychosomatic Research. 135: 110159. PMID 32464504 DOI: 10.1016/J.Jpsychores.2020.110159 |
0.388 |
|
| 2019 |
Sibai M, Mishlen K, Nunes EV, Levin FR, Mariani JJ, Bisaga A. A week-long outpatient induction onto XR-naltrexone in patients with opioid use disorder. The American Journal of Drug and Alcohol Abuse. 1-8. PMID 31860366 DOI: 10.1080/00952990.2019.1700265 |
0.456 |
|
| 2019 |
Levin FR, Mariani JJ, Pavlicova M, Choi CJ, Mahony AL, Brooks DJ, Bisaga A, Dakwar E, Carpenter KM, Naqvi N, Nunes EV, Kampman K. Extended release mixed amphetamine salts and topiramate for cocaine dependence: A randomized clinical replication trial with frequent users. Drug and Alcohol Dependence. 107700. PMID 31753736 DOI: 10.1016/J.Drugalcdep.2019.107700 |
0.38 |
|
| 2019 |
Nunes EV, Bisaga A, Krupitsky E, Nangia N, Silverman BL, Akerman SC, Sullivan MA. Opioid use and dropout from extended-release naltrexone in a controlled trial: Implications for mechanism. Addiction (Abingdon, England). PMID 31313402 DOI: 10.1111/Add.14735 |
0.45 |
|
| 2019 |
Williams AR, Nunes EV, Bisaga A, Levin FR, Olfson M. Development of a Cascade of Care for responding to the opioid epidemic. The American Journal of Drug and Alcohol Abuse. 1-10. PMID 30675818 DOI: 10.1080/00952990.2018.1546862 |
0.407 |
|
| 2019 |
Bisaga A. What should clinicians do as fentanyl replaces heroin? Addiction (Abingdon, England). PMID 30661265 DOI: 10.1111/Add.14522 |
0.355 |
|
| 2018 |
Sullivan MA, Bisaga A, Pavlicova M, Carpenter KM, Choi CJ, Mishlen K, Levin FR, Mariani JJ, Nunes EV. A Randomized Trial Comparing Extended-Release Injectable Suspension and Oral Naltrexone, Both Combined With Behavioral Therapy, for the Treatment of Opioid Use Disorder. The American Journal of Psychiatry. appiajp201817070732. PMID 30336703 DOI: 10.1176/Appi.Ajp.2018.17070732 |
0.48 |
|
| 2018 |
Tardelli VS, Lago MPPD, Mendez M, Bisaga A, Fidalgo TM. Contingency Management with pharmacologic treatment for Stimulant Use Disorders: A review. Behaviour Research and Therapy. 111: 57-63. PMID 30316027 DOI: 10.1016/J.Brat.2018.10.002 |
0.348 |
|
| 2018 |
Jones JD, Bisaga A, Metz VE, Manubay JM, Mogali S, Ciccocioppo R, Madera G, Doernberg M, Comer SD. The PPARγ Agonist Pioglitazone Fails to Alter the Abuse Potential of Heroin, But Does Reduce Heroin Craving and Anxiety. Journal of Psychoactive Drugs. 1-12. PMID 30204554 DOI: 10.1080/02791072.2018.1508789 |
0.361 |
|
| 2018 |
Williams AR, Nunes EV, Bisaga A, Pincus HA, Johnson KA, Campbell AN, Remien RH, Crystal S, Friedmann PD, Levin FR, Olfson M. Corrigendum to "Developing an opioid use disorder treatment cascade: A review of quality measures" [Journal of Substance Abuse Treatment 91 (2018) 57-68]. Journal of Substance Abuse Treatment. 92: 99. PMID 30032951 DOI: 10.1016/J.Jsat.2018.06.015 |
0.425 |
|
| 2018 |
Williams AR, Nunes EV, Bisaga A, Pincus HA, Johnson KA, Campbell AN, Remien RH, Crystal S, Friedmann PD, Levin FR, Olfson M. Developing an opioid use disorder treatment cascade: A review of quality measures. Journal of Substance Abuse Treatment. 91: 57-68. PMID 29910015 DOI: 10.1016/J.Jsat.2018.06.001 |
0.391 |
|
| 2018 |
Bisaga A, Mannelli P, Yu M, Nangia N, Graham CE, Tompkins DA, Kosten TR, Akerman SC, Silverman BL, Sullivan MA. Outpatient transition to extended-release injectable naltrexone for patients with opioid use disorder: A phase 3 randomized trial. Drug and Alcohol Dependence. 187: 171-178. PMID 29674251 DOI: 10.1016/J.Drugalcdep.2018.02.023 |
0.441 |
|
| 2018 |
Bisaga A, Mannelli P, Sullivan MA, Vosburg SK, Compton P, Woody GE, Kosten TR. Antagonists in the medical management of opioid use disorders: Historical and existing treatment strategies. The American Journal On Addictions. 27: 177-187. PMID 29596725 DOI: 10.1111/Ajad.12711 |
0.436 |
|
| 2017 |
Jones JD, Comer SD, Metz VE, Manubay JM, Mogali S, Ciccocioppo R, Martinez S, Mumtaz M, Bisaga A. Pioglitazone, a PPARγ agonist, reduces nicotine craving in humans, with marginal effects on abuse potential. Pharmacology, Biochemistry, and Behavior. PMID 29020601 DOI: 10.1016/J.Pbb.2017.10.002 |
0.33 |
|
| 2017 |
Williams AR, Barbieri V, Mishlen K, Levin FR, Nunes EV, Mariani JJ, Bisaga A. Long-term follow-up study of community-based patients receiving XR-NTX for opioid use disorders. The American Journal On Addictions. PMID 28328148 DOI: 10.1111/Ajad.12527 |
0.381 |
|
| 2017 |
Sullivan M, Bisaga A, Pavlicova M, Choi CJ, Mishlen K, Carpenter KM, Levin FR, Dakwar E, Mariani JJ, Nunes EV. Long-Acting Injectable Naltrexone Induction: A Randomized Trial of Outpatient Opioid Detoxification With Naltrexone Versus Buprenorphine. The American Journal of Psychiatry. appiajp201616050548. PMID 28068780 DOI: 10.1176/Appi.Ajp.2016.16050548 |
0.427 |
|
| 2017 |
Mishlen K, Barbieri VA, Sullivan MA, Bisaga A. Opioid use following an outpatient detoxification and induction onto XR-NTX: Testing the blockade as a predictor of retention in treatment Drug and Alcohol Dependence. 171: e146. DOI: 10.1016/J.Drugalcdep.2016.08.403 |
0.433 |
|
| 2016 |
Levin FR, Bisaga A, Sullivan MA, Williams AR, Cates-Wessel K. A review of a national training initiative to increase provider use of MAT to address the opioid epidemic. The American Journal On Addictions. 25: 603-609. PMID 28051841 DOI: 10.1111/Ajad.12454 |
0.372 |
|
| 2016 |
Williams AR, Bisaga A. From AIDS to Opioids - How to Combat an Epidemic. The New England Journal of Medicine. 375: 813-5. PMID 27579632 DOI: 10.1056/Nejmp1604223 |
0.378 |
|
| 2016 |
Bedi G, Shiffrin L, Vadhan NP, Nunes EV, Foltin RW, Bisaga A. Effects of levodopa-carbidopa-entacapone and smoked cocaine on facial affect recognition in cocaine smokers. Journal of Psychopharmacology (Oxford, England). PMID 26921145 DOI: 10.1177/0269881115626308 |
0.358 |
|
| 2015 |
Levin FR, Mariani JJ, Pavlicova M, Brooks D, Glass A, Mahony A, Nunes EV, Bisaga A, Dakwar E, Carpenter KM, Sullivan MA, Choi JC. Dronabinol and lofexidine for cannabis use disorder: A randomized, double-blind, placebo-controlled trial. Drug and Alcohol Dependence. PMID 26711160 DOI: 10.1016/J.Drugalcdep.2015.11.025 |
0.368 |
|
| 2015 |
Bisaga A, Sullivan MA, Glass A, Mishlen K, Pavlicova M, Haney M, Raby WN, Levin FR, Carpenter KM, Mariani JJ, Nunes EV. The effects of dronabinol during detoxification and the initiation of treatment with extended release naltrexone. Drug and Alcohol Dependence. PMID 26187456 DOI: 10.1016/J.Drugalcdep.2015.05.013 |
0.442 |
|
| 2015 |
Mogali S, Khan NA, Drill ES, Pavlicova M, Sullivan MA, Nunes E, Bisaga A. Baseline characteristics of patients predicting suitability for rapid naltrexone induction. The American Journal On Addictions / American Academy of Psychiatrists in Alcoholism and Addictions. 24: 258-64. PMID 25907815 DOI: 10.1111/Ajad.12180 |
0.417 |
|
| 2015 |
Levin FR, Mariani JJ, Bisaga A, Nunes EV. Ling et al.'s 'Sustained-release methylphenidate in a randomized trial of treatment of methamphetamine use disorder'. Addiction (Abingdon, England). 110: 875-6. PMID 25808040 DOI: 10.1111/Add.12885 |
0.41 |
|
| 2015 |
Sullivan MA, Bisaga A, Glass A, Mishlen K, Pavlicova M, Carpenter KM, Mariani JJ, Levin FR, Nunes EV. Opioid use and dropout in patients receiving oral naltrexone with or without single administration of injection naltrexone. Drug and Alcohol Dependence. 147: 122-9. PMID 25555621 DOI: 10.1016/J.Drugalcdep.2014.11.028 |
0.367 |
|
| 2015 |
Vaughan B, Mariani JJ, Pavlicova M, Glass A, Bisaga A, Nunes EV, Brooks DJ, Levin FR. Secondary analysis of smoking rates from a double-blind, placebo-controlled clinical trial of mixed-amphetamine salts and topiramate for cocaine dependence Drug and Alcohol Dependence. 146: e10. DOI: 10.1016/J.Drugalcdep.2014.09.709 |
0.348 |
|
| 2014 |
Kelly MA, Pavlicova M, Glass A, Mariani JJ, Bisaga A, Sullivan MA, Nunes EV, Levin FR. Do withdrawal-like symptoms mediate increased marijuana smoking in individuals treated with venlafaxine-XR? Drug and Alcohol Dependence. 144: 42-6. PMID 25283697 DOI: 10.1016/J.Drugalcdep.2014.06.040 |
0.328 |
|
| 2014 |
Mariani JJ, Pavlicova M, Mamczur AK, Bisaga A, Nunes EV, Levin FR. Open-label pilot study of quetiapine treatment for cannabis dependence. The American Journal of Drug and Alcohol Abuse. 40: 280-4. PMID 24963729 DOI: 10.3109/00952990.2014.884102 |
0.38 |
|
| 2014 |
Bisaga A, Sullivan MA, Glass A, Mishlen K, Carpenter KM, Mariani JJ, Levin FR, Nunes EV. A placebo-controlled trial of memantine as an adjunct to injectable extended-release naltrexone for opioid dependence. Journal of Substance Abuse Treatment. 46: 546-52. PMID 24560438 DOI: 10.1016/J.Jsat.2014.01.005 |
0.469 |
|
| 2014 |
Raby WN, Rubin EA, Garawi F, Cheng W, Mason E, Sanfilippo L, Lord S, Bisaga A, Aharonovich E, Levin F, McDowell D, Nunes EV. A randomized, double-blind, placebo-controlled trial of venlafaxine for the treatment of depressed cocaine-dependent patients. The American Journal On Addictions / American Academy of Psychiatrists in Alcoholism and Addictions. 23: 68-75. PMID 24313244 DOI: 10.1111/J.1521-0391.2013.12065.X |
0.384 |
|
| 2013 |
Hołuj M, Bisaga A, Popik P. Conditioned rewarding effects of morphine and methadone in mice pre-exposed to cocaine. Pharmacological Reports : Pr. 65: 1176-84. PMID 24399713 DOI: 10.1016/S1734-1140(13)71475-0 |
0.422 |
|
| 2013 |
Sullivan MA, Bisaga A, Mariani JJ, Glass A, Levin FR, Comer SD, Nunes EV. Naltrexone treatment for opioid dependence: does its effectiveness depend on testing the blockade? Drug and Alcohol Dependence. 133: 80-5. PMID 23827259 DOI: 10.1016/J.Drugalcdep.2013.05.030 |
0.455 |
|
| 2013 |
Levin FR, Mariani J, Brooks DJ, Pavlicova M, Nunes EV, Agosti V, Bisaga A, Sullivan MA, Carpenter KM. A randomized double-blind, placebo-controlled trial of venlafaxine-extended release for co-occurring cannabis dependence and depressive disorders. Addiction (Abingdon, England). 108: 1084-94. PMID 23297841 DOI: 10.1111/Add.12108 |
0.317 |
|
| 2012 |
Mariani JJ, Pavlicova M, Bisaga A, Nunes EV, Brooks DJ, Levin FR. Extended-release mixed amphetamine salts and topiramate for cocaine dependence: a randomized controlled trial. Biological Psychiatry. 72: 950-6. PMID 22795453 DOI: 10.1016/J.Biopsych.2012.05.032 |
0.381 |
|
| 2012 |
Sigmon SC, Bisaga A, Nunes EV, O'Connor PG, Kosten T, Woody G. Opioid detoxification and naltrexone induction strategies: recommendations for clinical practice. The American Journal of Drug and Alcohol Abuse. 38: 187-99. PMID 22404717 DOI: 10.3109/00952990.2011.653426 |
0.443 |
|
| 2012 |
Horey JT, Mariani JJ, Cheng WY, Bisaga A, Sullivan M, Nunes E, Levin FR. Comparison of substance use milestones in cannabis- and cocaine-dependent patients. Journal of Addictive Diseases. 31: 60-6. PMID 22356669 DOI: 10.1080/10550887.2011.642753 |
0.362 |
|
| 2011 |
Dakwar E, Nunes EV, Bisaga A, Carpenter KC, Mariani JP, Sullivan MA, Raby WN, Levin FR. A comparison of independent depression and substance-induced depression in cannabis-, cocaine-, and opioid-dependent treatment seekers. The American Journal On Addictions / American Academy of Psychiatrists in Alcoholism and Addictions. 20: 441-6. PMID 21838843 DOI: 10.1111/J.1521-0391.2011.00148.X |
0.332 |
|
| 2011 |
Bisaga A, Sullivan MA, Cheng WY, Carpenter KM, Mariani JJ, Levin FR, Raby WN, Nunes EV. A placebo controlled trial of memantine as an adjunct to oral naltrexone for opioid dependence. Drug and Alcohol Dependence. 119: e23-9. PMID 21715107 DOI: 10.1016/J.Drugalcdep.2011.05.019 |
0.45 |
|
| 2011 |
Mariani JJ, Cheng WY, Bisaga A, Sullivan M, Carpenter K, Nunes EV, Levin FR. Comparison of clinical trial recruitment populations: treatment-seeking characteristics of opioid-, cocaine-, and cannabis-using participants. Journal of Substance Abuse Treatment. 40: 426-30. PMID 21439756 DOI: 10.1016/J.Jsat.2011.01.005 |
0.449 |
|
| 2011 |
Popik P, Kos T, Zhang Y, Bisaga A. Memantine reduces consumption of highly palatable food in a rat model of binge eating. Amino Acids. 40: 477-85. PMID 20571841 DOI: 10.1007/S00726-010-0659-3 |
0.32 |
|
| 2010 |
Brooks AC, Comer SD, Sullivan MA, Bisaga A, Carpenter KM, Raby WM, Yu E, O'Brien CP, Nunes EV. Long-acting injectable versus oral naltrexone maintenance therapy with psychosocial intervention for heroin dependence: a quasi-experiment. The Journal of Clinical Psychiatry. 71: 1371-8. PMID 20673549 DOI: 10.4088/Jcp.09M05080Ecr |
0.334 |
|
| 2010 |
Bisaga A, Aharonovich E, Cheng WY, Levin FR, Mariani JJ, Raby WN, Nunes EV. A placebo-controlled trial of memantine for cocaine dependence with high-value voucher incentives during a pre-randomization lead-in period. Drug and Alcohol Dependence. 111: 97-104. PMID 20537812 DOI: 10.1016/J.Drugalcdep.2010.04.006 |
0.413 |
|
| 2009 |
Raby WN, Carpenter KM, Rothenberg J, Brooks AC, Jiang H, Sullivan M, Bisaga A, Comer S, Nunes EV. Intermittent marijuana use is associated with improved retention in naltrexone treatment for opiate-dependence. The American Journal On Addictions / American Academy of Psychiatrists in Alcoholism and Addictions. 18: 301-8. PMID 19444734 DOI: 10.1080/10550490902927785 |
0.447 |
|
| 2009 |
Levin FR, Mariani JJ, Secora A, Brooks D, Cheng WY, Bisaga A, Nunes E, Aharonovich E, Raby W, Hennessy G. Atomoxetine Treatment for Cocaine Abuse and Adult Attention-Deficit Hyperactivity Disorder (ADHD): A Preliminary Open Trial. Journal of Dual Diagnosis. 5: 41-56. PMID 19430599 DOI: 10.1080/15504260802628767 |
0.355 |
|
| 2009 |
Carpenter KM, Jiang H, Sullivan MA, Bisaga A, Comer SD, Raby WN, Brooks AC, Nunes EV. Betting on change: modeling transitional probabilities to guide therapy development for opioid dependence. Psychology of Addictive Behaviors : Journal of the Society of Psychologists in Addictive Behaviors. 23: 47-55. PMID 19290689 DOI: 10.1037/A0013049 |
0.406 |
|
| 2008 |
Aharonovich E, Amrhein PC, Bisaga A, Nunes EV, Hasin DS. Cognition, commitment language, and behavioral change among cocaine-dependent patients. Psychology of Addictive Behaviors : Journal of the Society of Psychologists in Addictive Behaviors. 22: 557-62. PMID 19071981 DOI: 10.1037/A0012971 |
0.315 |
|
| 2008 |
Mariani JJ, Horey J, Bisaga A, Aharonovich E, Raby W, Cheng WY, Nunes E, Levin FR. Antisocial behavioral syndromes in cocaine and cannabis dependence. The American Journal of Drug and Alcohol Abuse. 34: 405-14. PMID 18584570 DOI: 10.1080/00952990802122473 |
0.353 |
|
| 2008 |
Akerele E, Bisaga A, Sullivan MA, Garawi F, Comer SD, Thomas AA, Nunes EV, Kleber HD. Dextromethorphan and quinidine combination for heroin detoxification. The American Journal On Addictions / American Academy of Psychiatrists in Alcoholism and Addictions. 17: 176-80. PMID 18463993 DOI: 10.1080/10550490802019543 |
0.605 |
|
| 2008 |
Bisaga A, Kos T, Wójcikowski J, Daniel WA, Popik P. Brain levels of dextromethorphan and the intensity of opioid withdrawal in mice. Drug and Alcohol Dependence. 95: 147-51. PMID 18328640 DOI: 10.1016/J.Drugalcdep.2008.01.007 |
0.399 |
|
| 2008 |
Levin FR, Bisaga A, Raby W, Aharonovich E, Rubin E, Mariani J, Brooks DJ, Garawi F, Nunes EV. Effects of major depressive disorder and attention-deficit/hyperactivity disorder on the outcome of treatment for cocaine dependence. Journal of Substance Abuse Treatment. 34: 80-9. PMID 17574796 DOI: 10.1016/J.Jsat.2006.11.012 |
0.376 |
|
| 2007 |
Sullivan MA, Garawi F, Bisaga A, Comer SD, Carpenter K, Raby WN, Anen SJ, Brooks AC, Jiang H, Akerele E, Nunes EV. Management of relapse in naltrexone maintenance for heroin dependence. Drug and Alcohol Dependence. 91: 289-92. PMID 17681716 DOI: 10.1016/J.Drugalcdep.2007.06.013 |
0.45 |
|
| 2007 |
Vorel SR, Bisaga A, McKhann G, Kleber HD. Insula damage and quitting smoking. Science (New York, N.Y.). 317: 318-9; author reply . PMID 17641181 DOI: 10.1126/Science.317.5836.318C |
0.473 |
|
| 2006 |
Aharonovich E, Garawi F, Bisaga A, Brooks D, Raby WN, Rubin E, Nunes EV, Levin FR. Concurrent cannabis use during treatment for comorbid ADHD and cocaine dependence: effects on outcome. The American Journal of Drug and Alcohol Abuse. 32: 629-35. PMID 17127551 DOI: 10.1080/00952990600919005 |
0.407 |
|
| 2006 |
Levin FR, Brooks DJ, Bisaga A, Raby W, Rubin E, Aharonovich E, Nunes EV. Severity of dependence and motivation for treatment: comparison of marijuana- and cocaine-dependent treatment seekers. Journal of Addictive Diseases. 25: 33-41. PMID 16597571 DOI: 10.1300/J069V25N01_06 |
0.418 |
|
| 2006 |
Raby WN, Carpenter KM, Aharonovich E, Rubin E, Bisaga A, Levin F, Nunes EV. Temperament characteristics, as assessed by the tridimensional personality questionnaire, moderate the response to sertraline in depressed opiate-dependent methadone patients. Drug and Alcohol Dependence. 81: 283-92. PMID 16182468 DOI: 10.1016/J.Drugalcdep.2005.07.008 |
0.336 |
|
| 2006 |
Aharonovich E, Hasin DS, Brooks AC, Liu X, Bisaga A, Nunes EV. Cognitive deficits predict low treatment retention in cocaine dependent patients. Drug and Alcohol Dependence. 81: 313-22. PMID 16171953 DOI: 10.1016/J.Drugalcdep.2005.08.003 |
0.356 |
|
| 2006 |
Bisaga A, Aharonovich E, Garawi F, Levin FR, Rubin E, Raby WN, Nunes EV. A randomized placebo-controlled trial of gabapentin for cocaine dependence. Drug and Alcohol Dependence. 81: 267-74. PMID 16169160 DOI: 10.1016/J.Drugalcdep.2005.07.009 |
0.359 |
|
| 2006 |
Popik P, Wrobel M, Bisaga A. Reinstatement of morphine-conditioned reward is blocked by memantine. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 31: 160-70. PMID 15886718 DOI: 10.1038/Sj.Npp.1300760 |
0.421 |
|
| 2005 |
Bisaga A, Aharonovich E, Garawi F, Levin FR, Rubin E, Raby WN, Vosburg SK, Nunes EV. Utility of lead-in period in cocaine dependence pharmacotherapy trials. Drug and Alcohol Dependence. 77: 7-11. PMID 15607836 DOI: 10.1016/J.Drugalcdep.2004.06.007 |
0.385 |
|
| 2003 |
Popik P, Wrobel M, Rygula R, Bisaga A, Bespalov AY. Effects of memantine, an NMDA receptor antagonist, on place preference conditioned with drug and nondrug reinforcers in mice. Behavioural Pharmacology. 14: 237-44. PMID 12799526 DOI: 10.1097/00008877-200305000-00008 |
0.343 |
|
| 2003 |
Haney M, Bisaga A, Foltin RW. Interaction between naltrexone and oral THC in heavy marijuana smokers. Psychopharmacology. 166: 77-85. PMID 12491025 DOI: 10.1007/S00213-002-1279-8 |
0.387 |
|
| 2001 |
Bisaga A, Comer SD, Ward AS, Popik P, Kleber HD, Fischman MW. The NMDA antagonist memantine attenuates the expression of opioid physical dependence in humans. Psychopharmacology. 157: 1-10. PMID 11512037 DOI: 10.1007/S002130100739 |
0.61 |
|
| 2000 |
Bisaga A, Popik P, Bespalov AY, Danysz W. Therapeutic potential of NMDA receptor antagonists in the treatment of alcohol and substance use disorders. Expert Opinion On Investigational Drugs. 9: 2233-48. PMID 11060803 DOI: 10.1517/13543784.9.10.2233 |
0.362 |
|
| 2000 |
Bisaga A, Popik P. In search of a new pharmacological treatment for drug and alcohol addiction: N-methyl-D-aspartate (NMDA) antagonists. Drug and Alcohol Dependence. 59: 1-15. PMID 10706971 DOI: 10.1016/S0376-8716(99)00107-6 |
0.381 |
|
| 1997 |
Bisaga A, Gianelli P, Popik P. Opiate withdrawal with dextromethorphan. The American Journal of Psychiatry. 154: 584. PMID 9090360 |
0.323 |
|
| Show low-probability matches. |